Cargando…

Reduction of oxytocin-containing neurons and enhanced glymphatic activity in the hypothalamic paraventricular nucleus of patients with type 2 diabetes mellitus

Evidence from animal experiments has shown that the hypothalamic paraventricular nucleus (PVN) plays a key role in regulating body weight and blood glucose levels. However, it is unclear whether neuron populations in the human PVN are involved in the development of type 2 diabetes mellitus (T2DM). T...

Descripción completa

Detalles Bibliográficos
Autores principales: Correa-da-Silva, Felipe, Kalsbeek, Martin J., Gadella, Femke S., Oppersma, Jorn, Jiang, Wei, Wolff, Samantha E. C., Korpel, Nikita L., Swaab, Dick F., Fliers, Eric, Kalsbeek, Andries, Yi, Chun-Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318717/
https://www.ncbi.nlm.nih.gov/pubmed/37400893
http://dx.doi.org/10.1186/s40478-023-01606-w
_version_ 1785068098149154816
author Correa-da-Silva, Felipe
Kalsbeek, Martin J.
Gadella, Femke S.
Oppersma, Jorn
Jiang, Wei
Wolff, Samantha E. C.
Korpel, Nikita L.
Swaab, Dick F.
Fliers, Eric
Kalsbeek, Andries
Yi, Chun-Xia
author_facet Correa-da-Silva, Felipe
Kalsbeek, Martin J.
Gadella, Femke S.
Oppersma, Jorn
Jiang, Wei
Wolff, Samantha E. C.
Korpel, Nikita L.
Swaab, Dick F.
Fliers, Eric
Kalsbeek, Andries
Yi, Chun-Xia
author_sort Correa-da-Silva, Felipe
collection PubMed
description Evidence from animal experiments has shown that the hypothalamic paraventricular nucleus (PVN) plays a key role in regulating body weight and blood glucose levels. However, it is unclear whether neuron populations in the human PVN are involved in the development of type 2 diabetes mellitus (T2DM). To address this, we investigated the neuronal and glial populations in the PVN of 26 T2DM patients and 20 matched controls. Our findings revealed a significant reduction in oxytocin (Oxt) neuron density in the PVN of T2DM patients compared to controls, while other neuronal populations remained unchanged. This suggests that Oxt neurons may play a specific role in the pathophysiology of T2DM. Interestingly, the reduction in Oxt neurons was accompanied by a decreased melanocortinergic input in to the PVN as reflected by a reduction in alpha-MSH immunoreactivity. We also analysed two glial cell populations, as they are important for maintaining a healthy neural microenvironment. We found that microglial density, phagocytic capacity, and their proximity to neurons were not altered in T2DM patients, indicating that the loss of Oxt neurons is independent of changes in microglial immunity. However, we did observe a reduction in the number of astrocytes, which are crucial for providing trophic support to local neurons. Moreover, a specific subpopulation of astrocytes characterized by aquaporin 4 expression was overrepresented in T2DM patients. Since this subset of astrocytes is linked to the glymphatic system, their overrepresentation might point to alterations in the hypothalamic waste clearance system in T2DM. Our study shows selective loss of Oxt neurons in the PVN of T2DM individuals in association with astrocytic reduction and gliovascular remodelling. Therefore, hypothalamic Oxt neurons may represent a potential target for T2DM treatment modalities. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-023-01606-w.
format Online
Article
Text
id pubmed-10318717
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103187172023-07-05 Reduction of oxytocin-containing neurons and enhanced glymphatic activity in the hypothalamic paraventricular nucleus of patients with type 2 diabetes mellitus Correa-da-Silva, Felipe Kalsbeek, Martin J. Gadella, Femke S. Oppersma, Jorn Jiang, Wei Wolff, Samantha E. C. Korpel, Nikita L. Swaab, Dick F. Fliers, Eric Kalsbeek, Andries Yi, Chun-Xia Acta Neuropathol Commun Research Evidence from animal experiments has shown that the hypothalamic paraventricular nucleus (PVN) plays a key role in regulating body weight and blood glucose levels. However, it is unclear whether neuron populations in the human PVN are involved in the development of type 2 diabetes mellitus (T2DM). To address this, we investigated the neuronal and glial populations in the PVN of 26 T2DM patients and 20 matched controls. Our findings revealed a significant reduction in oxytocin (Oxt) neuron density in the PVN of T2DM patients compared to controls, while other neuronal populations remained unchanged. This suggests that Oxt neurons may play a specific role in the pathophysiology of T2DM. Interestingly, the reduction in Oxt neurons was accompanied by a decreased melanocortinergic input in to the PVN as reflected by a reduction in alpha-MSH immunoreactivity. We also analysed two glial cell populations, as they are important for maintaining a healthy neural microenvironment. We found that microglial density, phagocytic capacity, and their proximity to neurons were not altered in T2DM patients, indicating that the loss of Oxt neurons is independent of changes in microglial immunity. However, we did observe a reduction in the number of astrocytes, which are crucial for providing trophic support to local neurons. Moreover, a specific subpopulation of astrocytes characterized by aquaporin 4 expression was overrepresented in T2DM patients. Since this subset of astrocytes is linked to the glymphatic system, their overrepresentation might point to alterations in the hypothalamic waste clearance system in T2DM. Our study shows selective loss of Oxt neurons in the PVN of T2DM individuals in association with astrocytic reduction and gliovascular remodelling. Therefore, hypothalamic Oxt neurons may represent a potential target for T2DM treatment modalities. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-023-01606-w. BioMed Central 2023-07-03 /pmc/articles/PMC10318717/ /pubmed/37400893 http://dx.doi.org/10.1186/s40478-023-01606-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Correa-da-Silva, Felipe
Kalsbeek, Martin J.
Gadella, Femke S.
Oppersma, Jorn
Jiang, Wei
Wolff, Samantha E. C.
Korpel, Nikita L.
Swaab, Dick F.
Fliers, Eric
Kalsbeek, Andries
Yi, Chun-Xia
Reduction of oxytocin-containing neurons and enhanced glymphatic activity in the hypothalamic paraventricular nucleus of patients with type 2 diabetes mellitus
title Reduction of oxytocin-containing neurons and enhanced glymphatic activity in the hypothalamic paraventricular nucleus of patients with type 2 diabetes mellitus
title_full Reduction of oxytocin-containing neurons and enhanced glymphatic activity in the hypothalamic paraventricular nucleus of patients with type 2 diabetes mellitus
title_fullStr Reduction of oxytocin-containing neurons and enhanced glymphatic activity in the hypothalamic paraventricular nucleus of patients with type 2 diabetes mellitus
title_full_unstemmed Reduction of oxytocin-containing neurons and enhanced glymphatic activity in the hypothalamic paraventricular nucleus of patients with type 2 diabetes mellitus
title_short Reduction of oxytocin-containing neurons and enhanced glymphatic activity in the hypothalamic paraventricular nucleus of patients with type 2 diabetes mellitus
title_sort reduction of oxytocin-containing neurons and enhanced glymphatic activity in the hypothalamic paraventricular nucleus of patients with type 2 diabetes mellitus
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318717/
https://www.ncbi.nlm.nih.gov/pubmed/37400893
http://dx.doi.org/10.1186/s40478-023-01606-w
work_keys_str_mv AT correadasilvafelipe reductionofoxytocincontainingneuronsandenhancedglymphaticactivityinthehypothalamicparaventricularnucleusofpatientswithtype2diabetesmellitus
AT kalsbeekmartinj reductionofoxytocincontainingneuronsandenhancedglymphaticactivityinthehypothalamicparaventricularnucleusofpatientswithtype2diabetesmellitus
AT gadellafemkes reductionofoxytocincontainingneuronsandenhancedglymphaticactivityinthehypothalamicparaventricularnucleusofpatientswithtype2diabetesmellitus
AT oppersmajorn reductionofoxytocincontainingneuronsandenhancedglymphaticactivityinthehypothalamicparaventricularnucleusofpatientswithtype2diabetesmellitus
AT jiangwei reductionofoxytocincontainingneuronsandenhancedglymphaticactivityinthehypothalamicparaventricularnucleusofpatientswithtype2diabetesmellitus
AT wolffsamanthaec reductionofoxytocincontainingneuronsandenhancedglymphaticactivityinthehypothalamicparaventricularnucleusofpatientswithtype2diabetesmellitus
AT korpelnikital reductionofoxytocincontainingneuronsandenhancedglymphaticactivityinthehypothalamicparaventricularnucleusofpatientswithtype2diabetesmellitus
AT swaabdickf reductionofoxytocincontainingneuronsandenhancedglymphaticactivityinthehypothalamicparaventricularnucleusofpatientswithtype2diabetesmellitus
AT flierseric reductionofoxytocincontainingneuronsandenhancedglymphaticactivityinthehypothalamicparaventricularnucleusofpatientswithtype2diabetesmellitus
AT kalsbeekandries reductionofoxytocincontainingneuronsandenhancedglymphaticactivityinthehypothalamicparaventricularnucleusofpatientswithtype2diabetesmellitus
AT yichunxia reductionofoxytocincontainingneuronsandenhancedglymphaticactivityinthehypothalamicparaventricularnucleusofpatientswithtype2diabetesmellitus